BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28602279)

  • 1. An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans.
    Carvalho AMRS; Costa LE; Salles BCS; Santos TTO; Ramos FF; Lima MP; Chávez-Fumagalli MA; Silvestre BT; Portela ÁSB; Roatt BM; Silveira JAG; Gonçalves DU; Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Coelho EAF
    Cell Immunol; 2017 Aug; 318():42-48. PubMed ID: 28602279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein.
    Dias DS; Ribeiro PAF; Salles BCS; Santos TTO; Ramos FF; Lage DP; Costa LE; Portela ASB; Carvalho GB; Chávez-Fumagalli MA; Caligiorne RB; Oliveira JS; Magalhães-Soares DF; Silva ES; Galdino AS; Menezes-Souza D; Duarte MC; Gonçalves DU; Coelho EAF
    Parasitol Int; 2018 Jun; 67(3):344-350. PubMed ID: 29408435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Salles BCS; Dias DS; Steiner BT; Lage DP; Ramos FF; Ribeiro PAF; Santos TTO; Lima MP; Costa LE; Chaves AT; Chávez-Fumagalli MA; Fujiwaraa RT; Buenoa LL; Caligiorne RB; de Magalhães-Soares DF; Silveira JAG; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Immunobiology; 2019 Jan; 224(1):163-171. PubMed ID: 30266201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients.
    Lima MP; Costa LE; Duarte MC; Menezes-Souza D; Salles BCS; de Oliveira Santos TT; Ramos FF; Chávez-Fumagalli MA; Kursancew ACS; Ambrósio RP; Roatt BM; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Parasitol Res; 2017 Apr; 116(4):1197-1206. PubMed ID: 28150041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Recombinant Antigens for Sensitive Serodiagnosis of American Tegumentary Leishmaniasis Caused by Different Leishmania Species.
    Sato CM; Sanchez MC; Celeste BJ; Duthie MS; Guderian J; Reed SG; de Brito ME; Campos MB; de Souza Encarnação HV; Guerra J; de Mesquita TG; Pinheiro SK; Ramasawmy R; Silveira FT; de Assis Souza M; Goto H
    J Clin Microbiol; 2017 Feb; 55(2):495-503. PubMed ID: 27927927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Coelho EA; Costa LE; Lage DP; Martins VT; Garde E; de Jesus Pereira NC; Lopes EG; Borges LF; Duarte MC; Menezes-Souza D; de Magalhães-Soares DF; Chávez-Fumagalli MA; Soto M; Tavares CA
    Vet Parasitol; 2016 Jan; 215():63-71. PubMed ID: 26790739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Cysteine Proteinase B from Leishmania braziliensis and Its Domains: Promising Antigens for Serodiagnosis of Cutaneous and Visceral Leishmaniasis in Dogs.
    Bivona AE; Czentner L; Sanchez Alberti A; Cerny N; Cardoso Landaburu AC; Nevot C; Estévez O; Marco JD; Basombrio MA; Malchiodi EL; Cazorla SI
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up.
    Ribeiro PAF; Dias DS; Lage DP; Costa LE; Salles BCS; Steiner BT; Ramos FF; Lima MP; Santos TTO; Chaves AT; Chávez-Fumagalli MA; Fujiwara RT; Bueno LL; Caligiorne RB; de Magalhães-Soares DF; Silveira JAG; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):196-203. PubMed ID: 29941364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
    Machado AS; Ramos FF; Santos TTO; Costa LE; Ludolf F; Lage DP; Bandeira RS; Tavares GSV; Oliveira-da-Silva JA; Steiner BT; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Duarte MC; Machado-de-Ávila RA; Lyon S; Gonçalves DU; Caligiorne RB; Coelho EAF
    Exp Parasitol; 2020 Sep; 216():107941. PubMed ID: 32622940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Ludolf F; Steiner BT; Reis TAR; Santos TTO; Costa LE; Martins VT; Galvani NC; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Duarte MC; Menezes-Souza D; Silveira JAG; Moreira RLF; Machado-de-Ávila RA; Tupinambás U; Gonçalves DU; Coelho EAF
    Immunol Lett; 2020 Apr; 220():11-20. PubMed ID: 31981576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New serological tools for improved diagnosis of human tegumentary leishmaniasis.
    Costa LE; Salles BC; Alves PT; Dias AC; Vaz ER; Ramos FF; Menezes-Souza D; Duarte MC; Roatt BM; Chávez-Fumagalli MA; Tavares CA; Gonçalves DU; Rocha MO; Goulart LR; Coelho EA
    J Immunol Methods; 2016 Jul; 434():39-45. PubMed ID: 27090730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope.
    Rodrigues MR; Santos LMO; Miyazaki CK; Martins VT; Ludolf FR; Kursancew AC; Ramos FF; Dias DS; Oliveira JS; Vieira PMA; Roatt BM; Machado de Ávila RA; Gonçalves DU; Menezes-Souza D; Coelho EAF; Duarte MC
    J Immunol Methods; 2019 Nov; 474():112641. PubMed ID: 31400411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of Leishmania major superoxide dismutase B1: A potential target antigen for serodiagnosis of Leishmaniasis.
    Yeganeh F; Barkhordari F; Omidi M; Samiei A; Adeli A; Mahboudi F; Kamali-Sarvestani E
    Iran J Immunol; 2009 Sep; 6(3):130-40. PubMed ID: 19801786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].
    Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR
    Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomic road to acquire an accurate serological diagnosis for human tegumentary leishmaniasis.
    Lima BS; Pires SF; Fialho LC; Oliveira EJ; Machado-de-Avila RA; Chávez-Olórtegui C; Chapeaurouge AD; Perales J; Andrade HM
    J Proteomics; 2017 Jan; 151():174-181. PubMed ID: 27262223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.
    Menezes-Souza D; Mendes TA; Nagem RA; Santos TT; Silva AL; Santoro MM; de Carvalho SF; Coelho EA; Bartholomeu DC; Fujiwara RT
    PLoS One; 2014; 9(6):e99216. PubMed ID: 24921246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Recombinant Proteins for Serodiagnosis of Visceral Leishmaniasis in Humans and Dogs.
    Farahmand M; Nahrevanian H
    Iran Biomed J; 2016 Jul; 20(3):128-34. PubMed ID: 26883952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein.
    Lage DP; Machado AS; Ramos FF; Silveira PC; Dias DS; Ribeiro PAF; Tavares GSV; Costa LE; Santos TTO; Steiner BT; Fagundes MI; Chávez-Fumagalli MA; Lyon S; Moreira RLF; Duarte MC; Menezes-Souza D; Caligiorne RB; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
    Immunobiology; 2019 Jul; 224(4):477-484. PubMed ID: 31164242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.
    Porrozzi R; Santos da Costa MV; Teva A; Falqueto A; Ferreira AL; dos Santos CD; Fernandes AP; Gazzinelli RT; Campos-Neto A; Grimaldi G
    Clin Vaccine Immunol; 2007 May; 14(5):544-8. PubMed ID: 17314229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.